Women's Center for Pelvic Health (Mercy)
Charlotte, North Carolina, 28207, United States
Location status: Recruiting
NCT Number: NCT06918067
The purpose of this research study is to compare the urinary flow speed of two different female catheters in patients that use intermittent catheters to empty their bladder. The "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" will be compared to the "14 Fr Coloplast Micro Zone Luja Female Catheter." Participants will have one study visit that should take about an hour and will also receive a follow-up telephone call about one week after the visit.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Charlotte, North Carolina, 28207, United States
Location status: Recruiting
The purpose of this crossover study is to compare the urinary flow speed of two different female catheters manufactured by Coloplast, the "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" vs "14 Fr Coloplast Micro Zone Luja Female Catheter" in patients that use intermittent catheters to empty their bladder. Patients will be randomly assigned to group A or group B using a closed-envelope randomization method. Group A will self catheter with Luja, backfill with sterile fluid volume equal to amount of urine collected, then self-catheter with SpeediCath. Group B will self catheter with SpeediCath, backfill with sterile fluid volume equal to amount of urine collected, then self-catheter with Luja. Outcomes will be measured with office uroflow device.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
clean self-catheterization with 14 Fr Coloplast micro zone Luja female urinary catheter
clean self-catheterization with 14 Fr two eyelet Coloplast SpeediCath female urinary catheter
Time frame: Day 1
Amount of time (seconds) it takes the urine to be released. The normal urinary flow duration for women is 15-18 ml/sec. A lower average flow rate could indicate a problem with the bladder or urinary tract.
Time frame: Day 1
total urine volume (mL) measured by uroflow device
Time frame: Day 1
Peak flow (mL/sec) measured by uroflow device. Normal peak urine flow rates typically range from 15 to 25 mL/sec for women. Reduced flow rates or a slow stream can indicate urinary tract obstruction or other issues.
Time frame: Day 1
Time (seconds) to peak flow measured by uroflow device. A normal peak flow rate for women is typically between 15 and 25 mL/sec. A lower rate may indicate a blockage or obstruction in the urinary tract.
Time frame: Day 1
Mean flow (mL/sec) measured by uroflow device. Normal mean urine flow rates typically range from 15 to 25 mL/sec for women. A slow or low flow rate may mean there is an obstruction at the bladder neck or in the urethra or a weak bladder.
Time frame: Day 1
Total time (seconds) to void urine from beginning of urine flow to the end of flow, measured by uroflow device.
Time frame: Day 1
Patient's preference of catheter type by using the Patient Global Impression of Improvement (PGI-I) scale
Time frame: Day 1
Patient's Satisfaction and Comments on Use of Luja Catheter
Contact information is provided by the study sponsor or research team.
Michael Kennelly, MD
CONTACT
Zahra Bahrani-Mostafvai, PhD
CONTACT
Wake Forest University Health Sciences
Other
Comparison of Urinary Flow Speed Using 14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter Versus 14 Fr Coloplast Micro Zone Luja Female Catheter in Female Patients Using Intermittent Catheters
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07714694
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Libertyville, Illinois, United States
View Trial DetailsNCT07379814
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cleveland, Ohio, United States
View Trial DetailsNCT06163469
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Haven, Connecticut, United States
View Trial DetailsNCT03609580
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Hackensack, New Jersey, United States
View Trial Details